Evidence map›Paper›PMID 25708817›Full record

ArticleJournal of psychiatric research2015

Preliminary investigation of miRNA expression in individuals at high familial risk of bipolar disorder.

Rosie May Walker, Joanna Rybka, Susan Maguire Anderson, Helen Scott Torrance, Ruth Boxall, Jessika Elizabeth Sussmann, David John Porteous, Andrew Mark McIntosh, Kathryn Louise Evans

Open access · hybridAbstract read
In one paragraph

Article in Journal of psychiatric research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. The Regulatory Potential of Long Non-Coding RNAs in Bipolar Disorder.International journal of molecular sciences · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Targets and regulation of microRNA-652-3p in homoeostasis and disease.Journal of molecular medicine (Berlin, Germany) · 2021
    Review
  11. Review
  12. A miRNome analysis of drug-free manic psychotic bipolar patients versus healthy controls.European archives of psychiatry and clinical neuroscience · 2020
    Article
  13. Review
  14. Article
  15. Review
  16. Identification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Rosie May WalkerMedical Genetics Section, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. Electronic address: rwalke13@staffmail.ed.ac.uk.
Joanna RybkaMedical Genetics Section, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. Electronic address: joanna.rybka1@wp.pl.
Susan Maguire AndersonMedical Genetics Section, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. Electronic address: Susan.Anderson@igmm.ed.ac.uk.
Helen Scott TorranceMedical Genetics Section, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. Electronic address: Helen.Torrance@igmm.ed.ac.uk.
Ruth BoxallMedical Genetics Section, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. Electronic address: R.Boxall@sms.ed.ac.uk.
Jessika Elizabeth SussmannDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK. Electronic address: Jess.Sussmann@ed.ac.uk.
David John PorteousMedical Genetics Section, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK; Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh EH8 9JZ, UK. Electronic address: david.porteous@igmm.ed.ac.uk.
Andrew Mark McIntoshDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK; Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh EH8 9JZ, UK. Electronic address: andrew.mcintosh@ed.ac.uk.
Kathryn Louise EvansMedical Genetics Section, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK; Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, 7 George Square, Edinburgh EH8 9JZ, UK. Electronic address: Kathy.Evans@igmm.ed.ac.uk.
University of Edinburgh · GBMRC Institute of Genetics and Molecular Medicine · GBWestern General Hospital · GB

Funding

Testing the DISC1 pathway for functional genetic variation and epistasis in majorR01MH102068 · NIMH · COLD SPRING HARBOR LABORATORY · PI MCCOMBIE, WILLIAM RICHARD, PORTEOUS, DAVID J · 2013 to 2015
$2.0M
Chief Scientist Office ETM/181Medical Research Council MR/K026992/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/C011202/1NIMH NIH HHS R01 MH102068Wellcome Trust 104036
6 · The paper itself

Abstract

Bipolar disorder (BD) is a highly heritable psychiatric disorder characterised by recurrent episodes of mania and depression. Many studies have reported altered gene expression in BD, some of which may be attributable to the dysregulated expression of miRNAs. Studies carried out to date have largely studied medicated patients, so it is possible that observed changes in miRNA expression might be a consequence of clinical illness or of its treatment. We sought to establish whether altered miRNA expression might play a causative role in the development of BD by studying young, unmedicated relatives of individuals with BD, who are at a higher genetic risk of developing BD themselves (high-risk individuals). The expression of 20 miRNAs previously implicated in either BD or schizophrenia was measured by qRT-PCR in whole-blood samples from 34 high-risk and 46 control individuals. Three miRNAs, miR-15b, miR-132 and miR-652 were up-regulated in the high-risk individuals, consistent with previous reports of increased expression of these miRNAs in patients with schizophrenia. Our findings suggest that the altered expression of these miRNAs might represent a mechanism of genetic susceptibility for BD. Moreover, our observation of altered miRNA expression in the blood prior to the onset of illness provides hope that one day blood-based tests may aid in the risk-stratification and treatment of BD.

Indexed as

Family HealthAdolescentAdultBipolar DisorderFemaleGene Expression RegulationHumansMaleMicroRNAsYoung AdultMicroRNAsMIRN132 microRNA, humanMIRN15 microRNA, humanMIRN652 microRNA, humanBiomarkerBipolar disorderGABAGene expressionmiRNAPI3K/Akt

Identifiers

PMID25708817
PMCPMC4379383
OpenAlexW2011028341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.